Trial intelligence / Profile preview

DAMOCLE: DHA Supplementation in Obese Children

NCT04151758Phase 4Unknown

Sponsor
University of Milan
Start
Jan 2019
Primary completion
May 2021
Countries
1
01

Overview

Phase 4, open-label, single-arm trial, sponsored by University of Milan. Primary endpoints: Changes in gut microbiota composition at 8 months and Changes in short-chain fatty acid production by gut microbiota at 8 months. Status: unknown.

Beyond the preview

Go deeper on NCT04151758.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04151758.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call